Individualization of the starting dose of follitropin delta reduces the overall OHSS risk and/or the need of additional preventive interventions: Cumulative data over three stimulation cycles

ConclusionAn individualized follitropin delta dosing regimen decreased the risk of moderate/severe OHSS as well as the incidence of preventive interventions versus a conventional follitropin alfa regimen. An analysis per AMH quartile indicated that these statistically significant differences are driven mainly by patients with the highest pretreatment AMH levels.
Source: Reproductive BioMedicine Online - Category: Reproduction Medicine Source Type: research